Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials

By sjmartinez • January 26, 2024

Hoffmann-Vold AM, Volkmann ER, Allanore Y, Assassi S, de Vries-Bouwstra JK, Smith V, Tschoepe I, Loaiza L, Kanakapura M, Distler O. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials. Lancet Rheumatol. 2022 Oct;4(10):e679-e687. doi: 10.1016/S2665-9913(22)00215-6. PMID: 38265966.

Tags: Publications, Rheumatology

Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity

Li YR, Shen X, Zhu Y, Li Z, Hon R, Tian Y, Huang J, Zhao AS, Ma NY, Zhang C, Lin D, Sargsyan K, Yuan[...]

Pulmonary Rehabilitation Referral Practice Patterns Across Lung Transplantation Centers in the United States: A Multicenter Survey-Based Study

Deleija JD, Shah SZ, Felzer J, Tan X, Garvey C, DeCato TW, Pennington K, Sehgal S, Kennedy C, Kumar A. Pulmonary Rehabilitation Referral Practice Patterns[...]

Cardiovascular Outcomes in Patients With Cancer Undergoing Cardiac Implantable Electronic Device Implantation

Krishan S, Agarwal S, Munir MB, Ajijola O, Yang EH, Deswal A, Torbey E, Cheng R, Asad ZUA. Cardiovascular Outcomes in Patients With Cancer Undergoing[...]